1. Home
  2. BAND vs KROS Comparison

BAND vs KROS Comparison

Compare BAND & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BAND
  • KROS
  • Stock Information
  • Founded
  • BAND 2000
  • KROS 2015
  • Country
  • BAND United States
  • KROS United States
  • Employees
  • BAND 1100
  • KROS N/A
  • Industry
  • BAND Computer Software: Prepackaged Software
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BAND Technology
  • KROS Health Care
  • Exchange
  • BAND Nasdaq
  • KROS Nasdaq
  • Market Cap
  • BAND 431.4M
  • KROS 589.8M
  • IPO Year
  • BAND 2017
  • KROS 2020
  • Fundamental
  • Price
  • BAND $15.68
  • KROS $10.86
  • Analyst Decision
  • BAND Buy
  • KROS Buy
  • Analyst Count
  • BAND 8
  • KROS 11
  • Target Price
  • BAND $27.86
  • KROS $45.33
  • AVG Volume (30 Days)
  • BAND 239.7K
  • KROS 2.0M
  • Earning Date
  • BAND 02-26-2025
  • KROS 02-26-2025
  • Dividend Yield
  • BAND N/A
  • KROS N/A
  • EPS Growth
  • BAND N/A
  • KROS N/A
  • EPS
  • BAND N/A
  • KROS N/A
  • Revenue
  • BAND $703,904,000.00
  • KROS $651,000.00
  • Revenue This Year
  • BAND $25.91
  • KROS $303.39
  • Revenue Next Year
  • BAND $3.05
  • KROS N/A
  • P/E Ratio
  • BAND N/A
  • KROS N/A
  • Revenue Growth
  • BAND 18.76
  • KROS 8037.50
  • 52 Week Low
  • BAND $11.90
  • KROS $9.78
  • 52 Week High
  • BAND $25.02
  • KROS $73.00
  • Technical
  • Relative Strength Index (RSI)
  • BAND 32.68
  • KROS 20.25
  • Support Level
  • BAND $15.43
  • KROS $9.78
  • Resistance Level
  • BAND $16.20
  • KROS $16.49
  • Average True Range (ATR)
  • BAND 0.62
  • KROS 0.92
  • MACD
  • BAND -0.08
  • KROS 0.97
  • Stochastic Oscillator
  • BAND 10.71
  • KROS 14.52

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to large as well as small and medium-sized business, customers and is generally derived from usage and service fees. Usage revenue includes voice communication (driven by inbound and outbound minutes and toll-free minutes) and messaging communication (driven by the number of messages) that traverse the platform and network. Service fees include the provision and management of phone numbers and emergency services access.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: